A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected ...
Mar 1, 2021
0
28
A new study indicates that protein kinases, which initiate the process that erodes the body's immunity, significantly contribute to the immunodeficiency in HIV patients. Drugs that block these protein kinases may offer a ...
Mar 1, 2021
0
18
People living with the human immunodeficiency virus (HIV) who have a history of severe immunosuppression and at least one copy of the Alzheimer's disease-related gene variant APOE4, might see a compounded adverse effect on ...
Feb 22, 2021
0
7
Disruptions to HIV prevention and treatment strategies due to the pandemic could increase new HIV infections amongst men who have sex with men.
Feb 22, 2021
0
42
An investigational anti-HIV antibody delivered intravenously once every eight weeks safely and effectively prevented acquisition of HIV strains sensitive to that antibody, but did not significantly reduce overall HIV acquisition ...
Jan 27, 2021
0
9
For those who are diagnosed and have begun treatment for HIV, it is standard practice to regularly monitor viral load in the blood to assess response to treatment. A study of people living with HIV in Ethiopia shows that ...
Jan 25, 2021
0
6
A group of UNSW Sydney researchers has released a groundbreaking report expected to improve the lives of people with bloodborne viruses.
Dec 2, 2020
0
2
A new commentary co-authored by obstetricians across four provinces is encouraging pregnancy care providers to lean on Canada's evidence-based guidelines to support prospective parents living with and affected by HIV.
Dec 2, 2020
0
1
New HIV data, released today by the Kirby Institute at UNSW Sydney for World AIDS Day, are a reminder for Australia to sustain its efforts in HIV prevention amidst the COVID-19 pandemic.
Nov 30, 2020
0
4
Twenty years ago, treatment for HIV was a rare luxury in South Africa. Exorbitant costs and President Thabo Mbeki's government's fierce opposition to providing antiretroviral treatment (ART) kept it out of the public sector.
Nov 17, 2020
0
4
